NRF2 inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
During Mycobacterium tuberculosis (Mtb) infection, infected alveolar macrophages (AMs) initially up-regulate a NRF2 regulated cell-protective program, which is detrimental to host control and impedes AM activation, including MHC II expression. MHC II is critical for CD4 + T cell activation and host immunity during Mtb infection. We hypothesized that NRF2 regulates the MHC II pathway and AM antigen presentation to T cells. We found that NRF2 inhibits MHC II, but not MHC I, specifically in AMs, following Mtb infection in vitro and in vivo . NRF2 dampens Ciita and H2-Ab1 gene expression in uninfected AMs, and MHC II inhibition by NRF2 is retained following innate stimuli and IFNγ exposure. NRF2 expression in Mtb-infected AMs impedes their ability to activate ESAT6-specific CD4 + T cells. Thus, although NRF2 expression enhances cell-protective functions, it has the unexpected consequence of limiting innate-adaptive crosstalk, which can impair CD4+ T cell activation and host immunity during Mtb infection.
HIGHLIGHTS
-
NRF2 inhibits MHC II on AMs, but not DCs, MDMs, or PMNs, during Mtb infection
-
NRF2 inhibits Ciita and H2-Ab1 and total MHC II protein in AMs, but not in BMDMs
-
NRF2 blockade of AM MHC II is retained following PAMP and IFNγ stimulation
-
NRF2 impedes the activation of antigen-specific CD4 + T cells by Ams